APTAMERES DESTINES A ETRE UTILISES DANS L'INHIBITION ET/OU LA SUPPRESSION DE L'ACTIVATION DE TLR9

• 收藏
• 分享

专利权人:

BERLIN CURES GMBH

发明人:

HABERLAND, ANNEKATHRIN,WENZEL, KATRIN

申请号：

CA3044484

公开号：

CA3044484A1

申请日:

2017.10.27

申请国别(地区):

CA

年份:

2018

代理人:

摘要：

The present invention relates to new aptamer molecules for use in therapy of a subject by inhibiting or suppressing the activation of TLR9 in a cell, a method of inhibiting or suppressing the activation of TLR9 in a cell using such aptamer molecules, a pharmaceutical composition and a kit comprising such aptamer molecules and the use of aptamer molecules for inhibiting or suppressing TLR9 activation.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/